Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 6Colorectal Neoplasms 4Brain Neoplasms 3Radiodermatitis 2Pancreatic Neoplasms 2Pain, Postoperative 2Lung Neoplasms 2Leiomyoma 2Head and Neck Neoplasms 2Warts 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Diseases 1Sigmoid Neoplasms 1Severe Acute Respiratory Syndrome 1Sarcoma 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroinflammatory Diseases 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Mastocytosis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Injury 1Locally Advanced Cervical Cancer 1Limited Stage Small Cell Lung Cancer 1

Interventions

trilaciclib 1durvalumab 1Sodium Chloride 1Probiotics 1Immunotherapy 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Limited Stage Small Cell Lung Cancer × Sodium Chloride × 1 year × Clear all
NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Pharmacosmos A/S

Phase 3 Not yet recruiting
120 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡